Yale study finds aging of bone marrow accelerates atherosclerotic plaque formation
Aged bone marrow promotes the expansion of arterial smooth muscle cells and exacerbates the build-up of fatty deposits called atherosclerotic plaques in artery walls, according to a study by Yale’s Inamul Kabir and Daniel Greif.
Cardiologists push for a more diverse, inclusive healthcare workforce
The COVID-19 pandemic has had a disproportionately negative impact on racially and ethnically diverse patient populations. Inspired by this trend, representatives from the Association of Black Cardiologists hosted a virtual roundtable focused on increasing diversity in the healthcare workforce and improving patient care.Source: Cardiovascular Business
Christmas miracle: Waterbury boy gets a heart transplant
This Christmas, toddler Adam Silva Batista of Waterbury can play with his older brothers and the cars which are among their favorite toys. Another family’s gift made this sweet, simple family time possible. Less than three hours into his life, Adam’s mother, Debora DaSilva, noticed something wrong. His heartbeat pounded, too strong for the moment, as she held him in her arms. She alerted the nurses at Waterbury Hospital, who brought him immediately for an exam.Source: Waterbury Republican-American
Bypass Surgery Has Lower Risks Than Endovascular Therapy for Limb-threatening Ischemia
Bypass surgery in artiries leading to the legs was associated with a lower risk of cardiac events among patients with peripheral arterial disease who are candidates for two types of revascularization therapy, new research suggests.
No Survival Advantage for Either Torsemide or Furosemide in HF: TRANSFORM-HF
The choice of loop diuretic for decongestion in patients hospitalized with heart failure (HF) may make little difference to survival or readmission risk over the next year, at least when deciding between furosemide or torsemide, a randomized trial suggests.Source: Medscape
TRANSFORM-HF: Loop Diuretics Show No Difference in Mortality and Hospitalizations for Heart Failure
The results of the TRANSFORM-HF study, which explored the effects of two different therapies on heart failure outcomes, were featured during the first late-breaking session at the American Heart Association Scientific Sessions.